Bacterial endotoxins injected intravenously in small doses into animals and man produce, among other effects, a transient granulocytopenia followed by a marked granulocytosis (1) (2) (3) (4) (5) (6) (7) . Several comprehensive reviews have recently appeared which deal with the wide spectrum of biologic effects of these substances, including their relationship to the pathogenesis of fever, the development of tolerance to repeated administration, and effects upon host resistance to bacterial infection (5, 8, 9) .
Recent studies utilizing radioisotopic cell-labeling techniques have increased considerably the understanding of granulocyte kinetics. Athens and his associates estimate the total blood granulocytes in man to be made up of nearly equal compartments of circulating cells and cells marginated and sequestrated within the capillary bed (10) . The granulocytic elements in the marrow which are no longer capable of proliferation consist of a reserve of mature cells and cells in various stages of maturation which has been estimated to number 20 to 70 times the total blood granulocytes (7, 11, 12) . Craddock, Perry and Lawrence consider this marrow granulocyte reserve to be the source of the granulocytes that enter the circulation in response to leukocytopheresis (11) and endotoxin (1). Athens and co-workers have added evidence that the source of the endotoxin granulocytosis is the bone marrow (10) . No thereby serve as a means of assessing marrow function (7, 12) .
Because of their potency, the clinical dosage of purified endotoxins has been confined to a relatively narrow range. Recent investigators, using Pyrexal, the endotoxic polysaccharide derived from Salmonella abortus equi, have been able to obtain a granulocytic effect at a dose that did not produce severe systemic reactions (7, 13) . There is some disparity in dose levels at which unpleasant side effects were observed, but it is noteworthy that Keller and Heilmeyer reported no essential difference in the size of the granulocyte response where side effects were rare, as compared with doses of 0.1 to 0.2 pg where there was a fairly high incidence of headache, chills and fever (13) .
The broad objective of the present study was to determine the usefulness of endotoxin stimulation of granulocytosis as a measure of bone-marrow function. The approaches to this included: 1) a study of dose-response relationships for granulocyte increase, fever and selected other endotoxin effects; 2) determination of the variability of response among a group of normal volunteers; and 3) a study of the effect of repeated daily doses of endotoxin on the various parameters of response.
MATERIALS AND METHODS
The subjects studied were prisoners at the U. (2, 7, 13 Figure 2 . The seven control subjects had a The dose-granulocyte response is presented graphically in Figure 3 . The horizontal heavy line represents the mean baseline granulocyte count for the 69 subjects and was 4,450 (SE 60) cells per mm3. The response increased with dose up to 0.8 mpg per kg, after which no further increase in granulocyte increment was observed.
The time of peak granulocyte count after endotoxin injection varied with dose as shown in Table I and a dose-response plot in Figure 4 . subjective effects and leukocyte counts were studied in nine subjects given repeated doses of 5.0 mnug per kg. All subjects received this dose for 4 days. Three of these men were continued on the regimen for a total of six and three for a total of eight consecutive daily injections. The severity of unpleasant side effects declined progressively; after the third day complaints were infrequent, being virtually absent by Day 6. Headache was the single complaint persisting longest among these men. Figure 5 shows the development of fever, granulocytosis and lymphopenia on Days 1, 4 and 6. Mean fever indices on successive days are shown in Figure 6 . From an initial fever index of 42 on Day 1 there was a progressive decline to a mean index of 12 for the three subjects continued for 8 days. This is the value previously estimated to be the upper limit of the control response. Two additional subjects given 1.0 mfug per kg for 7 consecutive days showed indices of 11 and 20, respectively, on Day 1, and 11 and 15 on Day 7. On Day 8 each was given an injection of 5.0 1riug per kg and the indices remained essentially unchanged (11 and 11) .
Changes in granulocyte baseline and peak levels are shown in Figure 7 for the nine subjects given four consecutive daily injections of 5.0 mug of the endotoxin per kg. The initial mean baseline, Three of the subjects who had received 5 mug per kg per day for 4 consecutive days were given three additional such injections after a 2-day rest. The fever index continued its downward trend to a mean value of 11 after the last injection. The peak granulocyte increment remained high, however, averaging 5,000 after the final injection. Thus, the development of tolerance to the pyrogenic property of the endotoxin was not accompanied by tolerance to the property responsible for the granulocytic response. ing appreciable fever and side effects, making it possible to attain this cellular response at a low >vel of toxicity. The constancy of the peak granulocyte response as the dose was increased beyond this point contrasts with the progressively increasing fever, side effects, and release of immature granulocytes. It is thus apparent that the granulocytic and febrile responses to the pyrogen are separable and do not necessarily involve the same mechanism. Prolongation of the granulocytosis is seen at doses above those needed to produce the maximal cellular response. This may relate either to an increase in the time over which cells are released or, as suggested by Craddock, an increased peripheral survival time of immature granulocytes released in response to leukocytopheresis or other stimuli (18) .
It is noteworthy that a significant increase in immature granulocyte count was not observed until a fairly marked febrile response had developed, appearance of these young forms being associated with doses well above those required for maximal granulocytosis. It is not clear why these cells should be released at a time when a large reserve of more mature elements is presumably available. The fact that the appearance of large numbers of immature granulocytes did not increase the total granulocyte count at higher doses is also of interest. It is possible that a qualitative difference exists in the marrow stimulation between the dose that does not evoke an immature granulocyte response and one that causes appreciable numbers of these cells to enter the circulation. Larger doses of endotoxin could also exert a greater destructive effect on peripheral granulocytes, accelerating the turnover rate and thus imposing a greater drain on marrow reserves. A shift to the left accompanies the granulocytosis which is observed during malarial fever therapy and after fevers produced by means of a heat cabinet (19) . Fink noted no diminution in the over-all granulocyte response to Pyrexal when the fever was suppressed by acetylsalicylic acid (20) .
The initial leukopenia following the injection of endotoxin has been ascribed to alterations in the physical properties of the granulocytes, and perhaps the vascular epithelium, leading to increased sequestration within the capillary bed (reviewed in Ref. 8 ). Stetson found a correlation between degree of leukopenia and number of sequestered granulocytes in the lung tissue of rabbits injected with endotoxin (21) . The recent experiments of Athens and colleagues indicate that there is a shift of cells from the circulating to the marginal granulocyte pool at this time without a change in the total blood granulocyte pool (10) . We observed no consistent correlation between dose and degree of granulocytopenia or between degree of granulocytopenia and ensuing granulocytosis, but more frequent counts would be needed for quantitative evaluation of this phase of the response. Possibly the lymphopenia, which was dose related and particularly pronounced after the two highest doses used (Figure 1) , is also related to changes in surface properties of the cells and vascular epithelium, differing in time and dose relationship, however, from the changes observed with granulocytes. The lympholytic effect of adrenocortical hormones released in the over-all response to endotoxin must also be considered in this regard (22) .
As tolerance to the pyrogenic effect of endotoxin developed on repeated administration, the peak granulocyte increment remained essentially unaltered. This was true in spite of a daily drop in the preinjection granulocyte count. The percentage of immature forms, degree of mononucleocytopenia, and prolongation of granulocytosis also declined on successive days, so that by the sixth day of injection of 5 mug per kg the entire picture of response was similar to that seen after a single injection of a dose one-tenth that amount.
It should be recalled that the total granulocyte increment was stable over the dose range of 0.5 to 5 mng per kg, and that mature granulocyte release occurred at a considerably lower threshold of endotoxin stimulation than the other parameters of response observed here. The same pattern was followed as tolerance developed in an individual as in the dose-response study of the entire group. Although we found the increment in mature granulocytes to persist essentially unaltered after 8 successive days of endotoxin injections (three subjects), it seems likely that a longer series of injections would result in eventual diminution. Thus, Fukuda and Matsumoto (23) found that the leu'kocytosis resulting from the intravenous injection of typhoid vaccine in rabbits was greatly decreased by the twentieth consecutive day and Smith, Alderman and Gillespie (24) noted a diminution in the granulocytosis following intraperitoneal typhoid endotoxin in mice after the last of six injections given over a 2-week period.
A drop in the daily preinjection granulocyte count over the first 4 days occurred in every subject receiving repeated Pyrexal administration. This would not be expected if the marrow reserve and its availability were unlimited. Neither the total number of cells mobilized at each stimulation nor the rate of marrow repletion is known. Smith, Alderman and Cornfield demonstrated a 20 per cent depletion in the nucleated cells of the femoral marrow in mice after endotoxin administration, which persisted for at least 24 hours after injection (25) . The drop in peripheral counts presumably reflects a temporary diminution in the marrow granulocytic reserves due to an outflow in excess of the rate of influx from the proliferating pool. The diminution in the release of immature forms with repeated endotoxin administration may be considered evidence that proliferation is not keeping pace with the demand imposed by this stimulus. One should also consider the possibility that endotoxin itself affects the balance between marrow and circulating cells. For instance, inhibition of stem-cell proliferation would lead to depletion of the marrow reserve (see, however, Ref. 28 below); shortening of the maturation time would reduce the immature cell count; and damage to the circulating cells might effect a shortening of their peripheral life span with an over-all increase in rate of capillary bed sequestration or flow into the tissue spaces, or both. The possibility of direct damage to intramedullary granulocytes must also be considered.
Cessation of the downward trend in the preinjection count (and occasional increase in immature forms) toward the end of the series of daily injections may reflect a proliferative stimulus to granulocyte precursors, either as a direct effect of the endotoxin or indirectly as a result of repeated marrow depletion. Windle (27) . Recent studies have presented evidence that an increase in mitotic activity of all granulocyte precursor elements occurred after stimulation with pyrogen (28) . The evidence that endotoxin stimulation itself can alter bone marrow cellularity may compromise its usefulness as a sequential measure of marrow reserve, particularly in patients receiving myelosuppressive agents or in those having diseases associated with changing levels of myelosuppression.
In the use of endotoxin for test purposes, allowance should be made for the variability introduced by disease and therapy on the reactivity of individuals to this stimulus as well as on marrow function per se. The decreased reactivity to typhoid vaccine exhibited by patients having had malaria has been discussed. Keller and Heilmeyer noted severe side effects when Pyrexal was administered to patients having "splenic tumor" (13) and we encountered hypotenrsion, prolonged chills, and hyperpyrexia in two of our patients having lymphomatous disease when they were given 3 mug per kg, a dose relatively well tolerated by normal subjects (29) . Both of these patients developed an intense immature granulocytosis which may have indicated an alteration in marrow function but which could also have been a reflection of their increased sensitivity to the pyrogen, or perhaps a combination of both. Patients with cirrhosis of the liver have shown both an above average febrile reaction (17) and a subnormal granulocyte response (6, 30 (31) . Cortisone, which also affects reticuloendothelial system function, has likewise been shown to alter reactivity to endotoxin (31, 32) . The effects on the reticuloendothelial system of cytotoxic agents used in cancer chemotherapy require study in this regard.
There is a number of limiting factors which should be considered before attempting to interpret aberrant febrile and leukocytic response patterns to endotoxin stimulation. These include alterations in reactivity imposed by tolerance, various pathologic states, and certain forms of therapy, as well as changes in granulocyte dynamics relating to the test stimulus. In spite of these limitations the data presented here for normal subjects should provide a useful baseline for evaluating response to endotoxin. In this respect the data have pertinence not only to granulocyte studies, but also to other clinical applications. 2. A maximal rise in total granulocytes was obtained with 0.8 mkg per kg. Higher doses caused a marked shift to the left with prolonged granulocytosis as well as a progressive increase in fever, unpleasant side effects and degree of lymphopenia, but no further change in the total granulocyte increment.
3. With the repeated administration of the pyrogen the daily peak granulocyte increment remained uniform, although fever, side effects and the immature granulocyte increment decreased progressively.
Preinj ection counts declined steadily over the first few days, suggesting that the test material itself might affect granulocyte dynamics. 4 . Data have been obtained that may serve as a baseline for clinical use, provided one takes into account the variability imposed by altered reactivitv to endotoxin as well as changes in granulocyte dynamics caused by the agent itself or, particularlv in the case of repeated administration, by the reactions which the agent evokes.
